A systematic review of the literature exploring the role of primary care in genetic services

Family Practice

Volumn 16, Issue 4, 1999, Pages 426-445

  Emery, Jon ^a   Watson, Eila ^a   Rose, Peter ^a   Andermann, Anne ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Family practice; Genetic screening; Medical genetics; Primary health care; Review literature

Indexed keywords

ARTICLE; CLINICAL GENETICS; CYSTIC FIBROSIS; EDUCATION; GENERAL PRACTICE; GENETIC SCREENING; HEALTH CARE DELIVERY; MEDICAL GENETICS; NURSE PRACTITIONER; PATIENT REFERRAL; PRIMARY HEALTH CARE; WORKLOAD;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; FAMILY PRACTICE; GENETICS, MEDICAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES RESEARCH; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PHYSICIANS, FAMILY;

EID: 0032822382     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/16.4.426     Document Type: Article

References (65)

1. Harris R, Reid M. Medical genetic services in 31 countries: an overview. Eur J Hum Genet 1997; 5(Suppl 2): 3-21.
2. North West England Faculty of the RCGP. Genetics in Primary Care. Occasional Paper 77. A Report from the Faculty Genetics Group: Royal College of General Practitioners, 1998.
3. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG. Assessing Genetic Risks: Implications for Health and Social Policy. Washington: National Academy Press, 1994.
4. House of Commons Science and Technology Committee Report. Human Genetics: the Science and its Consequences. London: HMSO, 1995.
5. Hayflick S, Eiff M. Role of primary care providers in the delivery of genetics services. Commun Genet 1998; 1: 18-22.
6. Starfield B. Is primary care essential? Lancet 1994; 344: 1129-1133.
7. American Academy of Family Physicians. www.aafp.org.
8. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. Health Technol Assess 1998; 2: 1-112.
9. Boulton M, Williamson R. General practice and new genetics: what do general practitioners know about community carrier screening for cystic fibrosis? Pub Understanding Sci 1995; 4: 255-267.
10. Boulton M, Cummings C, Williamson R. The views of general practitioners on community carrier screening for cystic fibrosis. Br J Gen Pract 1996; 46: 299-301.
11. Firth HV, Lindenbaum RH. UK clinicians' knowledge of and attitudes to the prenatal diagnosis of single gene disorders. J Med Genet 1992; 29: 20-23.
12. Julian C, Ayme S, Huard P, Giraud F. Dissemination of genetic counseling and prenatal diagnosis: impact of the physicians' knowledge (in French). Rev Epidemiol Sante Publique 1986; 34: 365-372.
13. Shickle D, May A. Knowledge and perceptions of haemoglobinopathy carrier screening among general practitioners in Cardiff. J Med Genet 1989; 26: 109-112.
14. Fry A, Campbell H, Gudmundsdottir H et al. General practitioners' views on their role in cancer genetics and current practice. Fam Pract; in press.
15. Hofman KJ, Tambor ES, Chase GA, Geller G, Faden RR, Holtzman NA. Physicians' knowledge of genetics and genetic tests. Acad Med 1993; 68: 625-632.
16. Thomassen R, Tibben A, Niermeijer MF, van der Does E, van de Kamp JJ, Verhage F. Attitudes of Dutch general practitioners towards presymptomatic DNA-testing for Huntington disease. Clin Genet 1993; 43: 63-68.
17. Mennie ME, Holloway SM, Brock DJ. Attitudes of general practitioners to presymptomatic testing for Huntington's disease. J Med Genet 1990; 27: 224-227.
18. Sorensen SA, Fenger K. Huntington's chorea: general practitioners' knowledge about individuals' at-risk status. Scand J Prim Health Care 1989; 7: 49-52.
19. Neuenschwander H, Modell B. Audit of process of antenatal screening for sickle cell disorders at a north London hospital. Br Med J 1997; 315: 784-785.
20. Walpole IR, Watson C, Moore D, Goldblatt J, Bower C. Evaluation of a project to enhance knowledge of hereditary diseases and management. J Med Genet 1997; 34: 831-837.
21. Hem E, Hagen Cvd, Solaas M. Genetic disease in general practice. An interview study among general practitioners in Oppland and Oslo (In Norwegian). Tidsskr Nor Laegeforen 1994; 114: 1056-1057.
22. Weitz R. Barriers to acceptance of genetic counseling among primary care physicians. Soc Biol 1979; 26: 189-197.
23. Mennie M, Campbell H, Liston WA, Brock DJ. Attitudes of general practitioners to screening for cystic fibrosis. J Med Screen 1998; 5: 11-15.
24. Watson EK, Williamson R, Chapple J. Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public. Br J Gen Pract 1991; 41: 237-240.
25. Faden RR, Tambor ES, Chase GA, Geller G, Hofman KJ, Holtzman NA. Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening. Am J Med Genet 1994; 50: 1-11.
26. Geller G, Tambor ES, Chase GA, Hofman KJ, Faden RR, Holtzman NA. Incorporation of genetics in primary care practice. Will physicians do the counseling and will they be directive? [see comments]. Arch Fam Med 1993; 2: 1119-1125.
27. Geller G, Tambor E, Bernhardt B, Chase G. Physicians' attitudes toward disclosure of genetic information to third parties. J Law Med Ethics 1993; 21: 238-240.
28. Friedman LC, Plon SE, Cooper HP, Weinberg AD. Cancer genetics - survey of primary care physicians' attitudes and practices. J Cancer Educ 1997; 12: 199-203.
29. Watson E, Shickle D, Qureshi N, Emery J, Austoker J. The 'new genetics' and primary care: general practitioners' views on their role and educational needs. Fam Pract 1999; 16: 420-425.
30. Suchard M, Yudkin P, Sinsheimer J, Fowler G. General practitioners' views on genetic screening for common diseases. Br J Gen Pract 1999; 49: 45-46.
31. Kumar S, Gantley M. A qualitative study of general practitioners' concerns in providing genetic counselling for patients with a family history of common cancers. Unpublished paper, 1998.
32. O'Malley MS, Klabunde CN, McKinley ED, Newman B. Should we test women for inherited susceptibility to breast cancer? what do NC primary care physicians think. N C Med J 1997; 58: 176-180.
33. Johnson N, Lancaster T, Fuller A, Hodgson SV. The prevalence of a family history of cancer in general practice. Fam Pract 1995; 12: 287-289.
34. Suchard M, Yudkin P, Sinsheimer J. Are general practitioners willing and able to provide genetic services for common diseases? Unpublished paper.
35. de Bock GH, Perk DC, Oosterwijk JC, Hageman GC, Kievit J, Springer MP. Women worried about their familial breast cancer risk - a study on genetic advice in general practice [see comments]. Fam Pract 1997; 14: 40-43.
36. Kumar S, Gantley M. The changing definitions of genetic disease. Unpublished paper.
37. Summerton N, Garrood PV. The family history in family practice: a questionnaire study. Fam Pract 1997; 14: 285-288.
38. Weitz R. Medical norms and medical innovation: adoption of genetic counselling and new drugs among primary care physicians. Social Health Illness 1981; 3: 207-219.
39. Emery J, Kumar S, Smith H. Patient understanding of genetic principles and their expectations of genetic services within the NHS: a qualitative study. Commun Genet 1998; 1: 78-83.
40. Andermann A. Women who consult their general practitioner concerning a family history of breast cancer: a qualitative study. Unpublished, 1998.
41. Rose P, Humm E, Hey K, Jones L, Huson S. Family history taking and genetic counselling in primary care. Fam Pract 1999; 16: 78-83.
42. Qureshi N, Raeburn S, Modell B. Detecting genetic morbidity in primary care: a pilot study with consanguineous couples. Unpublished paper, 1997.
43. Qureshi N. The pyschological impact of family history screening in primary care. Unpublished paper, 1998.
44. Emery J, Walton R, Coulson A, Glasspool D, Ziebland S, Fox J. A qualitative evaluation of computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs). Br Med J 1999; in press.
45. Carr C, Chapatwala K, Nandedkar A. Hemoglobinopathies in a general and family practice setting. J Natl Med Assoc 1989; 81: 137-139.
46. Modell M, Wonke B, Anionwu E et al. A multidisciplinary approach for improving services in primary care: randomised controlled trial of screening for haemoglobin disorders. Br Med J 1998; 317: 788-791.
47. Hietala M, Aula P, Syvanen AC, Isoniemi A, Peltonen L, Palotie A. DNA-based carrier screening in primary healthcare: screening for aspartylglucosaminuria mutations in maternity health offices. Clin Chem 1996; 42: 1398-1404.
48. Cuckle H, Quirke P, Sehmi I et al. Antenatal screening for cystic fibrosis. Br J Obstet Gynaecol 1996; 103(8): 795-799.
49. Hartley NE, Scotcher D, Harris H et al. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet 1997; 34: 459-464.
50. Harris H, Scotcher D, Hartley N, Wallace A, Craufurd D, Harris R. Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. Br J Gen Pract 1996; 46: 225-227.
51. Harris H, Scotcher D, Hartley N, Wallace A, Craufurd D, Harris R. Cystic fibrosis carrier testing in early pregnancy by general practitioners [see comments]. Br Med J 1993; 306: 1580-1583.
52. Payne Y, Williams M, Cheadle J et al. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team. Clin Genet 1997; 51: 153-163.
53. Watson EK, Mayall E, Chapple J et al. Screening for carriers of cystic fibrosis through primary health care services. Br Med J 1991; 303: 504-507.
54. Bekker H, Modell M, Denniss G et al. Uptake of cystic fibrosis testing in primary care: supply push or demand pull? [see comments]. Br Med J 1993; 306: 1584-1586.
55. Bekker H, Denniss G, Modell M, Bobrow M, Marteau T. The impact of population based screening for carriers of cystic fibrosis. J Med Genet 1994; 31: 364-368.
56. Watson EK, Mayall ES, Lamb J, Chapple J, Williamson R. Psychological and social consequences of community carrier screening programme for cystic fibrosis [see comments]. Lancet 1992; 340: 217-220.
57. Axworthy D, Brock DJ, Bobrow M, Marteau TM. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group [see comments]. Lancet 1996; 347: 1443-1446.
58. Marteau TM, Dundas R, Axworthy D. Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychol 1997; 16: 51-62.
59. Morris JK, Oppenheimer PM. Cost comparison of different methods of screening for cystic fibrosis. J Med Screen 1995; 2: 22-27.
60. McManus R, Wilson S, Delaney B et al. Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews. Br Med J 1998; 317: 1562-1563.
61. Dickersin K, Scherer R, Lefebvre C. Identifying Relevant Studies for Systematic Reviews. Chalmers I, Altman D (series eds). Systematic Reviews: BMJ Publishing Group, 1995.
62. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health. Morbidity Statistics from General Practice. Fourth National Study, 1991-1992. London: HMSO, 1995.
63. Miedzybrodzka ZH, Hall MH, Mollison J et al. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening [see comments]. Br Med J 1995; 310: 353-357.
64. Stocking B. Promoting change in clinical care. Qual Health Care 1992; 1: 56-60.
65. Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience. Ciba Found Symp 1996; 197: 137-151.